These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12820143

  • 1. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.
    Saruc M, Ozden N, Turkel N, Ayhan S, Hock LM, Tuzcuoglu I, Yuceyar H.
    J Pharm Sci; 2003 Jul; 92(7):1386-95. PubMed ID: 12820143
    [Abstract] [Full Text] [Related]

  • 2. Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.
    Saruc M, Yuceyar H, Kucukmetin N, Demir MA, Kandiloglu AR.
    Hepatogastroenterology; 2002 Jul; 49(45):798-802. PubMed ID: 12063993
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
    Kim BH, Lee YJ, Kim W, Yoon JH, Jung EU, Park SJ, Kim YJ, Lee HS.
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1048-55. PubMed ID: 22726105
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.
    Lee HW, Lee JI, Um SH, Ahn SH, Chang HY, Park YK, Hong SP, Moon YM, Han KH.
    J Gastroenterol Hepatol; 2008 May; 23(5):729-35. PubMed ID: 18410608
    [Abstract] [Full Text] [Related]

  • 5. A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.
    Lim SG, Wai CT, Lee YM, Dan YY, Sutedja DS, Wee A, Suresh S, Wu YJ, Machin D, Lim CC, Fock KM, Koay E, Bowden S, Locarnini S, Ishaque SM.
    Antivir Ther; 2006 May; 11(2):245-53. PubMed ID: 16640105
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
    You J, Zhuang L, Cheng HY, Yan SM, Yu L, Huang JH, Tang BZ, Huang ML, Ma YL, Chongsuvivatwong V, Sriplung H, Geater A, Qiao YW, Wu RX.
    World J Gastroenterol; 2006 Nov 07; 12(41):6715-21. PubMed ID: 17075991
    [Abstract] [Full Text] [Related]

  • 7. [Antiviral therapy of chronic hepatitis B patients resistant to lamivudine].
    Cui SN, Wang MM.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec 07; 19(4):395-7. PubMed ID: 16416004
    [Abstract] [Full Text] [Related]

  • 8. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.
    Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, de Man RA, Niesters HG, Zondervan P, Hansen B, Schalm SW, HBV 99-01 Study Group, Rotterdam Foundation for Liver Research.
    Lancet; 2005 Dec 07; 365(9454):123-9. PubMed ID: 15639293
    [Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
    Andreone P, Cursaro C, Gramenzi A, Zavagliz C, Rezakovic I, Altomare E, Severini R, Franzone JS, Albano O, Ideo G, Bernardi M, Gasbarrini G.
    Hepatology; 1996 Oct 07; 24(4):774-7. PubMed ID: 8855175
    [Abstract] [Full Text] [Related]

  • 10. Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B.
    Vassiliadis T, Tziomalos K, Patsiaoura K, Zagris T, Giouleme O, Soufleris K, Grammatikos N, Theodoropoulos K, Mpoumponaris A, Dona K, Zezos P, Nikolaidis N, Orfanou-Koumerkeridou E, Balaska A, Eugenidis N.
    J Gastroenterol Hepatol; 2007 Oct 07; 22(10):1582-8. PubMed ID: 17683500
    [Abstract] [Full Text] [Related]

  • 11. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov 07; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 12-month courses of interferon-alpha-2b-lamivudine combination therapy and interferon-alpha-2b monotherapy among patients with untreated chronic hepatitis B.
    Yalcin K, Degertekin H, Yildiz F, Celik Y.
    Clin Infect Dis; 2003 Jun 15; 36(12):1516-22. PubMed ID: 12802750
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.
    Yang YF, Zhao W, Zhong YD, Yang YJ, Shen L, Zhang N, Huang P.
    Antiviral Res; 2008 Feb 15; 77(2):136-41. PubMed ID: 18078676
    [Abstract] [Full Text] [Related]

  • 14. Long-term conventional interferon alpha in combination with lamivudine for chronic hepatitis B: data from Turkey.
    Yilmaz S, Bayan K, Dursun M, Canoruç F, Paşa S, Saka G.
    Hepatogastroenterology; 2007 Dec 15; 54(80):2348-52. PubMed ID: 18265662
    [Abstract] [Full Text] [Related]

  • 15. Pegylated interferon Alfa-2b monotherapy and pegylated interferon Alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B.
    Kaymakoglu S, Oguz D, Gur G, Gurel S, Tankurt E, Ersöz G, Ozenirler S, Kalayci C, Poturoglu S, Cakaloglu Y, Okten A.
    Antimicrob Agents Chemother; 2007 Aug 15; 51(8):3020-2. PubMed ID: 17517832
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B.
    Helvaci M, Kizilgunesler A, Kasirga E, Ozbal E, Kuzu M, Sozen G.
    J Gastroenterol Hepatol; 2004 Jul 15; 19(7):785-91. PubMed ID: 15209626
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B.
    Chan HL, Hui AY, Wong VW, Chim AM, Wong ML, Sung JJ.
    Hepatology; 2005 Jun 15; 41(6):1357-64. PubMed ID: 15880608
    [Abstract] [Full Text] [Related]

  • 18. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
    Marcellin P, Lau GK, Bonino F, Farci P, Hadziyannis S, Jin R, Lu ZM, Piratvisuth T, Germanidis G, Yurdaydin C, Diago M, Gurel S, Lai MY, Button P, Pluck N, Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group.
    N Engl J Med; 2004 Sep 16; 351(12):1206-17. PubMed ID: 15371578
    [Abstract] [Full Text] [Related]

  • 19. A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected].
    You J, Zhuang L, Cheng HY, Yan SM, Qiao YW, Huang JH, Tang BZ, Ma YL, Wu GB, Qu JY, Wu RX.
    J Chin Med Assoc; 2005 Feb 16; 68(2):65-72. PubMed ID: 15759817
    [Abstract] [Full Text] [Related]

  • 20. Combination of Peginterferon alpha-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B- an Indian experience.
    Amarapurkar DN, Patel ND.
    Ann Hepatol; 2005 Feb 16; 4(1):56-9. PubMed ID: 15798663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.